InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,421.21
(
0.27%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

relyts

Send PM Follow Ignore
Followers 50
Posts 659
Boards Moderated 0
Alias Born 04/13/2012

relyts

Re: None

Sunday, 03/24/2013 7:15:35 AM

Sunday, March 24, 2013 7:15:35 AM

Post# of 158400
http://www.biocentury.com/products/hemaxellerate

Company: Bio-Matrix Scientific Group Inc.
Description: Patient-specific stem cell therapy
Mechanism of Action: Cell therapy
Latest Stage of Development: IND
Indication: Anemia

Nothing significant, but I've been keeping an eye on the status through BioCentury. The latest stage of development recently changed from "preclinical" to "IND"

"Exogenous endothelial cells as accelerators of hematopoietic reconstitution
Mizer JC, Ichim TE, Alexandrescu DT, Dasanu CA, Ramos F, Turner A, Woods EJ, Bogin V et al.
Journal of Translational Medicine 2012, 10:231 (21 November 2012)"

Second most viewed publication on http://www.translational-medicine.com/content/10/1/231. Popular resource for scientists.
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up